NCT07717099
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07717099
Title Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer (GUARD-QUANTUM)
Acronym GUARD-QUANTUM
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Hospital Santa Creu i Sant Pau Barcelona 08041 Spain Details
Complejo Hospitalario Universitario Materno-Infantil de Gran Canaria (CHUIMI) Las Palmas de Gran Canaria 35016 Spain Details
Hospital Clínico San Carlos Madrid 28040 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario La Paz Madrid 28046 Spain Details
Hospital Universitario HM Sanchinarro Madrid 28050 Spain Details
Hospital Universitario Central de Asturias (HUCA) Oviedo 33011 Spain Details
Hospital Universitario Marqués de Valdecilla Santander 39008 Spain Details
Complejo Hospitalario Universitario de Santiago (CHUS) Santiago de Compostela 15706 Spain Details
Instituto Valenciano de Oncología (IVO) Valencia 46009 Spain Details
Hospital Clínico Universitario de Valladolid (HCUV) Valladolid 47003 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field